Clinical trial sees dramatic results using radiation to treat breast cancerClinical trial sees dramatic results using radiation to treat breast cancer

Almost immediately after Theresa Greco was diagnosed with breast cancer in March, doctors asked her whether she wanted to participate in a clinical trial. The trial would do high-powered radiation targeted at her tumor prior to surgery, rather than the typical protocol of doing surgery first, then broader radiation.
Adjuvant Endocrine Therapy With Ovarian Function Suppression (OFS) by Breast Cancer IndexAdjuvant Endocrine Therapy With Ovarian Function Suppression (OFS) by Breast Cancer Index
This prognostic study assesses assess the Breast Cancer Index as a predictive biomarker of benefit from exemestane plus ovarian function suppression vs tamoxifen plus OFS and as a prognostic biomarker for premenopausal patients with hormone receptor–positive breast cancer.
Personalizing Adjuvant Endocrine Therapy for Breast CancerPersonalizing Adjuvant Endocrine Therapy for Breast Cancer
Oncology
Could a cancer vaccine developed long ago hold the key to long-term survival in breast cancer?Could a cancer vaccine developed long ago hold the key to long-term survival in breast cancer?

A small group of women with advanced breast cancer received a vaccine via a clinical trial more than 20 years ago. Today, they’re all still alive. Scientists say that kind of long-term survival is almost unheard of for patients with metastatic breast cancer, and it’s what caught the attention of researchers now.
Ozempic and Wegovy protect the heart, even without weight lossOzempic and Wegovy protect the heart, even without weight loss

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems tied not just to slimming down but to deeper biological effects on inflammation, blood pressure, and vessel health. Researchers say this could expand who Read More
WeightWatchers GLP-1 Clinic Review WeightWatchers GLP-1 Clinic Review

Post Content Post Content
Prescribing Trends of GLP-1 Receptor Agonists for Type 2 Diabetes or ObesityPrescribing Trends of GLP-1 Receptor Agonists for Type 2 Diabetes or Obesity
This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity. This cross-sectional study examines the US prescribing trends of glucagon-like peptide 1 (GLP-1) receptor agonists among individuals with type 2 diabetes and/or obesity.
GLP-1RAs and Pay-Per-Click Direct-to-Consumer AdvertisingGLP-1RAs and Pay-Per-Click Direct-to-Consumer Advertising
This cross-sectional study evaluates the use of direct-to-consumer advertising for a glucagon-like peptide-1 receptor agonist (GLP-1RA). This cross-sectional study evaluates the use of direct-to-consumer advertising for a glucagon-like peptide-1 receptor agonist (GLP-1RA).
Chicago father of child fighting cancer released on bond by immigration judgeChicago father of child fighting cancer released on bond by immigration judge

A Chicago man whose 16-year-old daughter is undergoing treatment for advanced cancer will be released on bond and return home, an immigration judge ruled Thursday
Study Homes In on Breast Cancer Risk With Hormonal Birth ControlStudy Homes In on Breast Cancer Risk With Hormonal Birth Control

(MedPage Today) — Use of hormonal contraceptives was associated with an increased risk of breast cancer, but the risk varied by progestin content, according to a large Swedish cohort study.
Among over 2 million adolescent girls and women, ever…